{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:10:44Z","timestamp":1793970644525,"version":"4.8.0"},"reference-count":220,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>The current pandemic caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus disease 2019 (COVID-19) has caused about 114 million accumulated cases and 2.53 million deaths worldwide. Previous pieces of evidence suggest that SARS-CoV-2 may affect the central nervous system (CNS) and cause neurological symptoms in COVID-19 patients. It is also known that angiotensin-converting enzyme-2 (ACE2), the primary receptor for SARS-CoV-2 infection, is expressed in different brain areas and cell types. Thus, it is hypothesized that infection by this virus could generate or exacerbate neuropathological alterations. However, the molecular mechanisms that link COVID-19 disease and nerve damage are unclear. In this review, we describe the routes of SARS-CoV-2 invasion into the central nervous system. We also analyze the neuropathologic mechanisms underlying this viral infection, and their potential relationship with the neurological manifestations described in patients with COVID-19, and the appearance or exacerbation of some neurodegenerative diseases.<\/jats:p>","DOI":"10.3389\/fneur.2021.660087","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T02:44:00Z","timestamp":1618195440000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":60,"title":["Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection"],"prefix":"10.3389","volume":"12","author":[{"given":"Mar","family":"Pacheco-Herrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis O.","family":"Soto-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazmin M.","family":"Flores-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos M.","family":"Villegas-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo M.","family":"Le\u00f3n-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola A.","family":"Mart\u00ednez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Berenice","family":"Campa-C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Ap\u00e1tiga-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin N.","family":"Corniel-Taveras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesabelle de J.","family":"Dominguez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor Manuel","family":"Blanco-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Luna-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-824313-8.00001-2","article-title":"Chapter 1 - The First 50 days of COVID-19: A Detailed Chronological Timeline and Extensive Review of Literature Documenting the Pandemic","author":"Allam","year":"","journal-title":"Surveying the Covid-19 Pandemic and its Implications"},{"key":"B2","unstructured":"Coronavirus Disease (COVID-19)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/22221751.2020.1729071","article-title":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","volume":"9","author":"Zhang","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B4","unstructured":"COVID-192021"},{"key":"B5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/JCMA.0000000000000270","article-title":"The outbreak of COVID-19: an overview","volume":"83","author":"Wu","year":"2020","journal-title":"J Chinese Medical Assoc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1101\/2020.02.06.20020974","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E113","DOI":"10.1148\/radiol.2020200527","article-title":"Essentials for radiologists on COVID-19: an update-radiology scientific expert panel","volume":"296","author":"Kanne","year":"2020","journal-title":"Radiology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.3389\/fimmu.2020.02132","article-title":"Cytokine storm in COVID-19: \u201cwhen you come out of the storm, you won't be the same person who walked in.\u201d","volume":"11","author":"Castelli","year":"2020"},{"key":"B10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender differences in patients with COVID-19: focus on severity and mortality","volume":"8","author":"Jin","year":"2020","journal-title":"Front Public Health."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1183\/13993003.00547-2020","article-title":"Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis","volume":"55","author":"Guan","year":"2020","journal-title":"Eur Respir J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3389\/fneur.2020.01039","article-title":"Neurological aspects of SARS-CoV-2 infection: mechanisms and manifestations","volume":"11","author":"Guadarrama-Ortiz","year":"2020","journal-title":"Front Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e20200477","DOI":"10.1590\/0037-8682-0477-2020","article-title":"Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19","volume":"53","author":"Puccioni-Sohler","year":"2020","journal-title":"Rev Soc Bras Med Trop."},{"key":"B15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cns.13372","article-title":"Neurological manifestations in COVID-19 caused by SARS-CoV-2","volume":"26","author":"Baig","year":"2020","journal-title":"CNS Neurosci Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents."},{"key":"B17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1213\/ANE.0000000000004845","article-title":"Coronaviruses and SARS-CoV-2: a brief overview","volume":"131","author":"Ludwig","year":"2020","journal-title":"Anesth Analg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3181\/0903-MR-94","article-title":"Coronavirus diversity, phylogeny and interspecies jumping","volume":"234","author":"Woo","year":"2009","journal-title":"Exp Biol Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol Sin."},{"key":"B24","doi-asserted-by":"publisher","first-page":"104759","DOI":"10.1016\/j.antiviral.2020.104759","article-title":"A potential role for integrins in host cell entry by SARS-CoV-2","volume":"177","author":"Sigrist","year":"2020","journal-title":"Antiviral Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"16471","DOI":"10.1038\/s41598-020-71936-5","article-title":"SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals","volume":"10","author":"Lam","year":"2020","journal-title":"Sci Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/diseases4030026","article-title":"Human coronaviruses: a review of virus-host interactions","volume":"4","author":"Lim","year":"2016","journal-title":"Diseases."},{"key":"B30","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.arcmed.2020.05.012","article-title":"Structural proteins in severe acute respiratory syndrome coronavirus-2","volume":"51","author":"Satarker","year":"2020","journal-title":"Arch Med Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12250-020-00207-4","article-title":"Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools","volume":"35","author":"Fu","year":"2020","journal-title":"Virol Sin."},{"key":"B33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur J Intern Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12967-020-02339-3","article-title":"Why tocilizumab could be an effective treatment for severe COVID-19?","volume":"18","author":"Fu","year":"2020","journal-title":"J Transl Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/22221751.2020.1736644","article-title":"A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses","volume":"9","author":"Fung","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1004077","DOI":"10.1371\/journal.ppat.1004077","article-title":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis","volume":"10","author":"Nieto-Torres","year":"2014","journal-title":"PLoS Pathog."},{"key":"B38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41577-020-0321-6","article-title":"The potential danger of suboptimal antibody responses in COVID-19","volume":"20","author":"Iwasaki","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","article-title":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins","volume":"451","author":"Wang","year":"2014","journal-title":"Biochem Biophys Res Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N Engl J Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"155151","DOI":"10.1016\/j.cyto.2020.155151","article-title":"COVID-19 cytokine storm: the anger of inflammation","volume":"133","author":"Mahmudpour","year":"2020","journal-title":"Cytokine."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3389\/fimmu.2020.02163","article-title":"Experimental models for the study of central nervous system infection by SARS-CoV-2","volume":"11","author":"Sanclemente-Alaman","year":"2020","journal-title":"Front Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jneuroim.2005.01.007","article-title":"Transcriptome profile within the mouse central nervous system and activation of myelin-reactive T cells following murine coronavirus infection","volume":"162","author":"Gruslin","year":"2005","journal-title":"J Neuroimmunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0002-9440(10)64402-1","article-title":"Virus-induced demyelination in nude mice is mediated by gamma delta T cells","volume":"161","author":"Dandekar","year":"2002","journal-title":"Am J Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"9862","DOI":"10.1128\/JVI.79.15.9862-9871.2005","article-title":"Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release","volume":"79","author":"Choi","year":"2005","journal-title":"J Virol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fcimb.2018.00311","article-title":"Intracranial inoculation is more potent than intranasal inoculation for inducing optic neuritis in the mouse hepatitis virus-induced model of multiple sclerosis","volume":"8","author":"Singh","year":"2018","journal-title":"Front Cell Infect Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cell.2020.08.028","article-title":"Effects of COVID-19 on the nervous system","volume":"183","author":"Iadecola","year":"2020","journal-title":"Cell."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.15.150912","article-title":"The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier","author":"Buzhdygan","year":"2020","journal-title":"bioRxiv."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/jmv.26570","article-title":"Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection","volume":"93","author":"Liu","year":"2020","journal-title":"J Med Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/ene.14491","article-title":"Cytokine release syndrome-associated encephalopathy in patients with COVID-19","volume":"28","author":"Perrin","year":"2020","journal-title":"Eur J Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1021\/acschemneuro.0c00346","article-title":"Cytokine storm in COVID19: a neural hypothesis","volume":"11","author":"Ur","year":"2020","journal-title":"ACS Chem Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/STROKEAHA.111.000481","article-title":"Response to letter regarding article, \u201cimpact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging.\u201d","volume":"44","author":"Pena-Silva","year":"2013"},{"key":"B56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12987-020-00216-1","article-title":"The potential role of microvascular pathology in the neurological manifestations of coronavirus infection","volume":"17","author":"Maclean","year":"2020","journal-title":"Fluids Barriers CNS."},{"key":"B57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2045-8118-11-10","article-title":"A new look at cerebrospinal fluid circulation","volume":"11","author":"Brinker","year":"2014","journal-title":"Fluids Barriers CNS."},{"key":"B58","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.virusres.2014.09.011","article-title":"Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis","volume":"194","author":"Desforges","year":"2014","journal-title":"Virus Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fncel.2020.00229","article-title":"SARS-CoV-2 dissemination through peripheral nerves explains multiple organ injury","volume":"14","author":"Fenrich","year":"2020","journal-title":"Front Cell Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/jmv.26105","article-title":"Potential neuroinvasive pathways of SARS-CoV-2: deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19)","volume":"92","author":"Baig","year":"2020","journal-title":"J Med Virol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jmii.2020.05.017","article-title":"Anosmia and olfactory tract neuropathy in a case of COVID-19","volume":"54","author":"Li","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3174\/ajnr.A6793","article-title":"Brain imaging of patients with COVID-19: findings at an academic institution during the height of the outbreak in New York City","volume":"41","author":"Lin","year":"2020","journal-title":"AJNR Am J Neuroradiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jad.2020.08.031","article-title":"First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder","volume":"277","author":"Lu","year":"2020","journal-title":"J Affect Disord."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","article-title":"Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review","volume":"77","author":"Zubair","year":"2020","journal-title":"JAMA Neurol."},{"key":"B65","first-page":"199","article-title":"Propagation of viruses along neuron networks by transsynaptic passage\u2013a contribution to the pathogenesis of rabies","volume":"14","author":"Gosztonyi","year":"1986","journal-title":"Tierarztl Prax."},{"key":"B66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/cne.23171","article-title":"Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication","volume":"521","author":"Li","year":"2013","journal-title":"J Comp Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.tim.2015.01.002","article-title":"Axonal spread of neuroinvasive viral infections","volume":"23","author":"Taylor","year":"2015","journal-title":"Trends Microbiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"592214","DOI":"10.3389\/fncel.2020.592214","article-title":"Neuropathobiology of COVID-19: the role for Glia","volume":"14","author":"Tremblay","year":"2020","journal-title":"Front Cell Neurosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","article-title":"A mouse model of SARS-CoV-2 infection and pathogenesis","volume":"28","author":"Sun","year":"2020","journal-title":"Cell Host Microbe."},{"key":"B71","doi-asserted-by":"publisher","first-page":"R373","DOI":"10.1152\/ajpregu.00292.2006","article-title":"Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system","volume":"292","author":"Doobay","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3892\/ijmm.2020.4646","article-title":"Coexpression of peripheral olfactory receptors with SARSCoV2 infection mediators: potential implications beyond loss of smell as a COVID19 symptom","volume":"46","author":"Kerslake","year":"2020","journal-title":"Int J Mol Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1523\/JNEUROSCI.0587-16.2016","article-title":"Glutamate-mediated blood-brain barrier opening: implications for neuroprotection and drug delivery","volume":"36","author":"Vazana","year":"2016","journal-title":"J Neurosci."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.18.20105494","article-title":"Risk of ischemic stroke in patients with covid-19 versus patients with influenza","author":"Merkler","year":"2020","journal-title":"MedRxiv."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1021\/acschemneuro.0c00210","article-title":"Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age","volume":"11","author":"Bilinska","year":"2020","journal-title":"ACS Chem Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2217\/fon-2020-0571","article-title":"The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer","volume":"16","author":"Mollica","year":"2020","journal-title":"Future Oncol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.bbrc.2020.09.042","article-title":"The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues","volume":"533","author":"Qiao","year":"2020","journal-title":"Biochem Biophys Res Commun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/44.5.8627002","article-title":"Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice","volume":"44","author":"Mentzel","year":"1996","journal-title":"J Histochem Cytochem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1210\/er.2014-1035","article-title":"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors","volume":"35","author":"Mulvihill","year":"2014","journal-title":"Endocr Rev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ajpath.2015.09.014","article-title":"Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the middle east respiratory syndrome","volume":"186","author":"Meyerholz","year":"2016","journal-title":"Am J Pathol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.bbi.2020.10.007","article-title":"Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases","volume":"91","author":"Li","year":"2020","journal-title":"Brain Behav Immun"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/jmv.25987","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs","volume":"92","author":"Choudhury","year":"2020","journal-title":"J Med Virol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4172\/jcs.1000111","article-title":"Angiotensin receptors: structure, function, signaling and clinical applications","volume":"1","author":"Singh","year":"","journal-title":"J Cell Signal."},{"key":"B85","doi-asserted-by":"publisher","first-page":"30726","DOI":"10.3390\/ijms20030726","article-title":"Role of the angiotensin pathway and its target therapy in epilepsy management","volume":"20","author":"Krasniqi","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","volume":"81","author":"Gurwitz","year":"2020","journal-title":"Drug Dev Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"83003","DOI":"10.3390\/ijms21083003","article-title":"COVID-19 and RAS: unravelling an unclear relationship","volume":"21","author":"D'ardes","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1016\/j.jmb.2018.06.024","article-title":"Virus-Receptor interactions: the key to cellular invasion","volume":"430","author":"Maginnis","year":"2018","journal-title":"J Mol Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3389\/fphar.2020.00912","article-title":"New strategy for COVID-19: an evolutionary role for RGD motif in SARS-CoV-2 and potential inhibitors for virus infection","volume":"11","author":"Yan","year":"2020","journal-title":"Front Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.arr.2016.04.010","article-title":"Lysosomal cathepsins and their regulation in aging and neurodegeneration","volume":"32","author":"Stoka","year":"2016","journal-title":"Ageing Res Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","article-title":"Lifting the mask on neurological manifestations of COVID-19","volume":"16","author":"Pezzini","year":"2020","journal-title":"Nat Rev Neurol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/glia.22891","article-title":"NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients","volume":"63","author":"Johann","year":"2015","journal-title":"Glia."},{"key":"B93","doi-asserted-by":"publisher","first-page":"10248","DOI":"10.15252\/emmm.201810248","article-title":"Inflammasomes in neuroinflammatory and neurodegenerative diseases","volume":"11","author":"Voet","year":"2019","journal-title":"EMBO Mol Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/glia.23728","article-title":"The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins","volume":"68","author":"Deora","year":"2020","journal-title":"Glia."},{"key":"B95","doi-asserted-by":"publisher","first-page":"573095","DOI":"10.3389\/fneur.2020.573095","article-title":"The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains","volume":"11","author":"Chen","year":"2020","journal-title":"Front Neurol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e9610","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol Syst Biol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"H1377","DOI":"10.1152\/ajpheart.00331.2008","article-title":"Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis","volume":"295","author":"Lovren","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"105131","DOI":"10.1016\/j.nbd.2020.105131","article-title":"The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier","volume":"146","author":"Buzhdygan","year":"2020","journal-title":"Neurobiol Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"100127","DOI":"10.1016\/j.bbih.2020.100127","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: insights and perspectives","volume":"7","author":"Vargas","year":"2020","journal-title":"Brain Behav Immun Health."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12031-020-01767-6","article-title":"Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations","volume":"19","author":"Jha","year":"2021","journal-title":"J Mol Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-015-1511-3","article-title":"Neurotropic virus infections as the cause of immediate and delayed neuropathology","volume":"131","author":"Ludlow","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"247","DOI":"10.31887\/DCNS.2013.15.3\/osporns","article-title":"Structure and function of complex brain networks","volume":"15","author":"Sporns","year":"2013","journal-title":"Dialogues Clin Neurosci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B107","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10735-020-09915-3","article-title":"COVID-19 and multiorgan failure: a narrative review on potential mechanisms","volume":"51","author":"Mokhtari","year":"2020","journal-title":"J Mol Histol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JAD-200581","article-title":"Neurobiology of COVID-19","volume":"76","author":"Fotuhi","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/bjh.16725","article-title":"Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"189","author":"Xiong","year":"2020","journal-title":"Br J Haematol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-020-01896-0","article-title":"Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports","volume":"17","author":"Najjar","year":"2020","journal-title":"J Neuroinflammation."},{"key":"B113","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1016\/j.febslet.2011.04.066","article-title":"How do immune cells overcome the blood-brain barrier in multiple sclerosis?","volume":"585","author":"Larochelle","year":"2011","journal-title":"FEBS Lett."},{"key":"B114","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fpsyt.2017.00083","article-title":"Neurovascular unit dysfunction and blood-brain barrier hyperpermeability contribute to schizophrenia neurobiology: a theoretical integration of clinical and experimental evidence","volume":"8","author":"Najjar","year":"2017","journal-title":"Front Psychiatry."},{"key":"B115","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1152\/physrev.00039.2016","article-title":"Neuroimmune interactions: from the brain to the immune system and vice versa","volume":"98","author":"Dantzer","year":"2018","journal-title":"Physiol Rev."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s10072-020-04449-8","article-title":"Early Guillain-Barre syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital","volume":"41","author":"Ottaviani","year":"2020","journal-title":"Neurol Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.1148\/radiol.2020201187","article-title":"COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features","volume":"296","author":"Poyiadji","year":"2020","journal-title":"Radiology."},{"key":"B118","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/jnnp-2020-323522","article-title":"Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke","volume":"91","author":"Al Saiegh","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B119","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature."},{"key":"B120","doi-asserted-by":"publisher","first-page":"30691","DOI":"10.3390\/ijms20030691","article-title":"Astrocytes in flavivirus infections","volume":"20","author":"Potokar","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1016\/j.febslet.2005.05.046","article-title":"Viroporin activity of murine hepatitis virus E protein","volume":"579","author":"Madan","year":"2005","journal-title":"FEBS Lett."},{"key":"B122","doi-asserted-by":"publisher","first-page":"112360","DOI":"10.3390\/cells9112360","article-title":"COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain relevance","volume":"9","author":"Achar","year":"2020","journal-title":"Cells."},{"key":"B123","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.3390\/v7072777","article-title":"NLRP3 inflammasome activation by viroporins of animal viruses","volume":"7","author":"Guo","year":"2015","journal-title":"Viruses."},{"key":"B124","doi-asserted-by":"publisher","first-page":"105738","DOI":"10.1016\/j.biocel.2020.105738","article-title":"Viroporins and inflammasomes: a key to understand virus-induced inflammation","volume":"122","author":"Farag","year":"2020","journal-title":"Int J Biochem Cell Biol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ni.1861","article-title":"Influenza virus activates inflammasomes via its intracellular M2 ion channel","volume":"11","author":"Ichinohe","year":"2010","journal-title":"Nat Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","article-title":"Gasdermins: effectors of pyroptosis","volume":"27","author":"Kovacs","year":"2017","journal-title":"Trends Cell Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"aav1447","DOI":"10.1126\/sciimmunol.aav1447","article-title":"Gasdermin D activity in inflammation and host defense","volume":"4","author":"Lieberman","year":"2019","journal-title":"Sci Immunol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1590\/0004-282x20200051","article-title":"Neurological complications in patients with SARS-CoV-2 infection: a systematic review","volume":"78","author":"Munhoz","year":"2020","journal-title":"Arq Neuropsiquiatr."},{"key":"B129","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1212\/WNL.0000000000010354","article-title":"COVID-19-related encephalopathy responsive to high-dose glucocorticoids","volume":"95","author":"Pugin","year":"2020","journal-title":"Neurology."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42399-020-00369-y","article-title":"Treatment-refractory headache in the setting of COVID-19 pneumonia: migraine or meningoencephalitis? case report","volume":"369","author":"Arca","year":"2020","journal-title":"SN Compr Clin Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1111\/head.13940","article-title":"Case series of headache characteristics in COVID-19: headache can be an isolated symptom","volume":"60","author":"Toptan","year":"2020","journal-title":"Headache."},{"key":"B133","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s10194-020-01188-1","article-title":"Headache characteristics in COVID-19 pandemic-a survey study","volume":"21","author":"Uygun","year":"2020","journal-title":"J Headache Pain."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/acn3.51210","article-title":"Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients","volume":"7","author":"Liotta","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.genhosppsych.2020.05.008","article-title":"Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement","volume":"65","author":"Beach","year":"2020","journal-title":"Gen Hosp Psychiatry."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N Engl J Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s11239-020-02228-y","article-title":"COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature","volume":"50","author":"Tan","year":"2020","journal-title":"J Thromb Thrombolysis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","volume":"277","author":"Lechien","year":"2020","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3174\/ajnr.A6675","article-title":"Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI","volume":"41","author":"Aragao","year":"2020","journal-title":"AJNR Am J Neuroradiol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3389\/fneur.2020.00956","article-title":"COVID-19-related anosmia: the olfactory pathway hypothesis and early intervention","volume":"11","author":"Gori","year":"2020","journal-title":"Front Neurol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.amjoto.2020.102581","article-title":"COVID-19 and anosmia: a review based on up-to-date knowledge","volume":"41","author":"Meng","year":"2020","journal-title":"Am J Otolaryngol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/alr.22593","article-title":"Potential pathogenesis of ageusia and anosmia in COVID-19 patients","volume":"10","author":"Vaira","year":"2020","journal-title":"Int Forum Allergy Rhinol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","article-title":"COVID-19 and neuromuscular disorders","volume":"94","author":"Guidon","year":"2020","journal-title":"Neurology."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barre syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Engl J Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"25","author":"Abu-Rumeileh","year":"2020","journal-title":"J Neurol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"154","DOI":"10.29399\/npa.26148","article-title":"Coronavirus disease 2019 (COVID-19) from the point of view of neurologists: observation of neurological findings and symptoms during the combat against a pandemic","volume":"57","author":"Ozdag Acarli","year":"2020","journal-title":"Noro Psikiyatr Ars."},{"key":"B148","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coph.2008.12.007","article-title":"CGRP receptors in the control of pain and inflammation","volume":"9","author":"Benemei","year":"2009","journal-title":"Curr Opin Pharmacol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1526-4610.2006.00483.x","article-title":"Calcitonin gene-related peptide (CGRP) and migraine","volume":"46","author":"Durham","year":"2006","journal-title":"Headache."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/head.13902","article-title":"Spectrum of headaches associated with SARS-CoV-2 infection: study of healthcare professionals","volume":"60","author":"Porta-Etessam","year":"2020","journal-title":"Headache."},{"key":"B151","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14336\/AD.2020.0917","article-title":"Neurological manifestations of COVID-19: causality or coincidence?","volume":"12","author":"Zhao","year":"2021","journal-title":"Aging Dis."},{"key":"B152","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1750-3639.2001.tb00384.x","article-title":"Viral induced demyelination","volume":"11","author":"Stohlman","year":"2001","journal-title":"Brain Pathol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jneuroim.2017.01.003","article-title":"Viral-induced suppression of self-reactive T cells: lessons from neurotropic coronavirus-induced demyelination","volume":"308","author":"Savarin","year":"2017","journal-title":"J Neuroimmunol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3390\/ijms22041804","article-title":"The impact of SARS-CoV-2 infection on the development of neurodegeneration in multiple sclerosis","volume":"22","author":"Dziedzic","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B155","doi-asserted-by":"publisher","first-page":"102377","DOI":"10.1016\/j.msard.2020.102377","article-title":"Multiple sclerosis following SARS-CoV-2 infection","volume":"45","author":"Palao","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B156","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.nmd.2020.08.354","article-title":"Guillain-Barre-Strohl syndrome and COVID-19: case report and literature review","volume":"30","author":"Diez-Porras","year":"2020","journal-title":"Neuromuscul Disord."},{"key":"B157","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/NRL.0000000000000291","article-title":"Guillain-Barre syndrome as a neurological complication of novel COVID-19 infection: a case report and review of the literature","volume":"25","author":"Paybast","year":"2020","journal-title":"Neurologist."},{"key":"B158","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3389\/fneur.2020.00909","article-title":"COVID-19 and Guillain-Barre syndrome: a case report and review of literature","volume":"11","author":"Zito","year":"2020","journal-title":"Front Neurol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/jmv.26207","article-title":"Encephalopathy in patients with COVID-19: a review","volume":"93","author":"Garg","year":"2021","journal-title":"J Med Virol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"001641","DOI":"10.12890\/2020_001641","article-title":"Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered?","volume":"7","author":"Lorenzo Villalba","year":"2020","journal-title":"Eur J Case Rep Intern Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1001\/jama.2020.6771","article-title":"Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection","volume":"323","author":"Spinato","year":"2020","journal-title":"JAMA."},{"key":"B162","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/alr.22592","article-title":"Self-reported olfactory loss associates with outpatient clinical course in COVID-19","volume":"10","author":"Yan","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"abc5801","DOI":"10.1126\/sciadv.abc5801","article-title":"Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia","volume":"6","author":"Brann","year":"2020","journal-title":"Sci Adv."},{"key":"B164","doi-asserted-by":"publisher","first-page":"E91","DOI":"10.3174\/ajnr.A6827","article-title":"Reply","volume":"41","author":"Nicholson","year":"2020","journal-title":"AJNR Am J Neuroradiol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"e2016","DOI":"10.1212\/WNL.0000000000010116","article-title":"Early postmortem brain MRI findings in COVID-19 non-survivors","volume":"95","author":"Coolen","year":"2020","journal-title":"Neurology."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med."},{"key":"B167","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/bcpt.13533","article-title":"Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety","volume":"128","author":"Breining","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s13054-020-03078-z","article-title":"Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series","volume":"24","author":"Doi","year":"2020","journal-title":"Crit Care."},{"key":"B169","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1128\/AAC.00754-20","article-title":"Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19","volume":"64","author":"Hoffmann","year":"2020","journal-title":"Antimicrob Agents Chemother."},{"key":"B170","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N Engl J Med."},{"key":"B171","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s13054-020-03364-w","article-title":"Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study","volume":"24","author":"Kooistra","year":"2020","journal-title":"Crit Care."},{"key":"B173","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1016\/S2665-9913(20)30170-3","article-title":"GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study","volume":"2","author":"De Luca","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Group","year":"2021","journal-title":"N Engl J Med."},{"key":"B175","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMc2019373","article-title":"Neuropathological Features of Covid-19","volume":"383","author":"Solomon","year":"2020","journal-title":"N Engl J Med."},{"key":"B176","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/S0140-6736(20)31282-4","article-title":"Early evidence of pronounced brain involvement in fatal COVID-19 outcomes","volume":"395","author":"Von Weyhern","year":"2020","journal-title":"Lancet."},{"key":"B177","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40478-020-01024-2","article-title":"Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage","volume":"8","author":"Al-Dalahmah","year":"2020","journal-title":"Acta Neuropathol Commun."},{"key":"B178","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","article-title":"Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19","volume":"24","author":"Meinhardt","year":"2020","journal-title":"Nat Neurosci."},{"key":"B179","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1016\/S2666-5247(20)30144-0","article-title":"Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study","volume":"1","author":"Schurink","year":"2020","journal-title":"Lancet Microbe."},{"key":"B181","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1212\/WNL.0000000000009700","article-title":"COVID-19 presenting with ophthalmoparesis from cranial nerve palsy","volume":"95","author":"Dinkin","year":"2020","journal-title":"Neurology."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42399-020-00522-7","article-title":"SARS-CoV-2, an underestimated pathogen of the nervous system","volume":"7","author":"Jakhmola","year":"2020","journal-title":"SN Compr Clin Med."},{"key":"B183","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/cid\/ciaa525","article-title":"Olfactory and gustatory dysfunction in coronavirus disease 2019 (COVID-19)","volume":"71","author":"Luers","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B184","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.resp.2004.03.015","article-title":"Functional organization of the parabrachial complex and intertrigeminal region in the control of breathing","volume":"143","author":"Chamberlin","year":"2004","journal-title":"Respir Physiol Neurobiol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1212\/01.WNL.0000099171.26943.D0","article-title":"Peripheral nerve disease in SARS: report of a case","volume":"61","author":"Chao","year":"2003","journal-title":"Neurology."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/archneur.61.11.1669","article-title":"Neuromuscular disorders in severe acute respiratory syndrome","volume":"61","author":"Tsai","year":"2004","journal-title":"Arch Neurol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijid.2014.09.003","article-title":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia","volume":"29","author":"Saad","year":"2014","journal-title":"Int J Infect Dis."},{"key":"B188","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2009.09.023","article-title":"Viral infection leading to brain dysfunction: more prevalent than appreciated?","volume":"64","author":"Van Den Pol","year":"2009","journal-title":"Neuron."},{"key":"B189","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mds.870070210","article-title":"Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease","volume":"7","author":"Fazzini","year":"1992","journal-title":"Mov Disord."},{"key":"B190","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ana.410310511","article-title":"Detection of coronavirus RNA and antigen in multiple sclerosis brain","volume":"31","author":"Murray","year":"1992","journal-title":"Ann Neurol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1128\/JVI.73.4.3338-3350.1999","article-title":"Acute and persistent infection of human neural cell lines by human coronavirus OC43","volume":"73","author":"Arbour","year":"1999","journal-title":"J Virol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-81-322-1777-0_6","article-title":"Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans","volume":"807","author":"Desforges","year":"2014","journal-title":"Adv Exp Med Biol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.3233\/JAD-2012-129037","article-title":"Neurovascular defects and faulty amyloid-beta vascular clearance in Alzheimer's disease","volume":"33","author":"Sagare","year":"2013","journal-title":"J Alzheimers Dis."},{"key":"B194","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med."},{"key":"B195","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/JAD-142853","article-title":"Herpes simplex virus type 1 and other pathogens are key causative factors in sporadic Alzheimer's disease","volume":"48","author":"Harris","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"B196","doi-asserted-by":"publisher","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS ONE."},{"key":"B197","doi-asserted-by":"publisher","first-page":"092536","DOI":"10.1101\/2020.05.13.092536","article-title":"Network analysis and transcriptome profiling identify autophagic and mitochondrial dysfunctions in SARS-CoV-2 infection","volume":"2020","author":"Singh","year":"2020","journal-title":"bioRxiv"},{"key":"B198","doi-asserted-by":"publisher","first-page":"665","DOI":"10.14573\/altex.2006111s","article-title":"Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2","volume":"37","author":"Bullen","year":"2020","journal-title":"ALTEX."},{"key":"B199","doi-asserted-by":"publisher","first-page":"e106230","DOI":"10.15252\/embj.2020106230","article-title":"SARS-CoV-2 targets neurons of 3D human brain organoids","volume":"39","author":"Ramani","year":"2020","journal-title":"EMBO J."},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.25.169946","article-title":"Neuroinvasion of SARS-CoV-2 in human and mouse brain","author":"Song","year":"2020","journal-title":"bioRxiv."},{"key":"B201","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol Neurodegener."},{"key":"B202","doi-asserted-by":"publisher","first-page":"30286","DOI":"10.3390\/healthcare8030286","article-title":"Impact of COVID-19 on Alzheimer's disease risk: viewpoint for research action","volume":"8","author":"Abate","year":"2020","journal-title":"Healthcare."},{"key":"B203","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics."},{"key":"B204","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"Mcnab","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41440-020-0455-8","article-title":"Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors\u2014lessons from available evidence and insights into COVID-19","volume":"43","author":"Kai","year":"2020","journal-title":"Hypertension Res."},{"key":"B206","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","article-title":"Viral parkinsonism","volume":"1792","author":"Jang","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"B207","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/1353-8020(96)00006-5","article-title":"Viral etiology of Parkinson's disease: focus on influenza A virus","volume":"2","author":"Yamada","year":"1996","journal-title":"Parkinsonism Relat Disord."},{"key":"B208","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3389\/fneur.2019.00652","article-title":"Infectious etiologies of parkinsonism: pathomechanisms and clinical implications","volume":"10","author":"Limphaibool","year":"2019","journal-title":"Front Neurol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet."},{"key":"B210","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J Parkinsons Dis."},{"key":"B211","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur J Neurol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat Disord."},{"key":"B213","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","article-title":"Microglial physiology: unique stimuli, specialized responses","volume":"27","author":"Ransohoff","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jneuroim.2003.10.013","article-title":"Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections)","volume":"147","author":"Ringheim","year":"2004","journal-title":"J Neuroimmunol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fneur.2019.00122","article-title":"Inflammation, infectious triggers, and Parkinson's disease","volume":"10","author":"Caggiu","year":"2019","journal-title":"Front Neurol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/vim.2018.0075","article-title":"Immunology of west nile virus infection and the role of alpha-synuclein as a viral restriction factor","volume":"32","author":"Lesteberg","year":"2019","journal-title":"Viral Immunol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/dna.2016.3488","article-title":"Alpha-synuclein, a novel viral restriction factor hiding in plain sight","volume":"35","author":"Massey","year":"2016","journal-title":"DNA Cell Biol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"4784268","DOI":"10.1155\/2018\/4784268","article-title":"Linking neuroinflammation and neurodegeneration in Parkinson's disease","volume":"2018","author":"Gelders","year":"2018","journal-title":"J Immunol Res."},{"key":"B220","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1002\/jmv.26046","article-title":"Is the brain a reservoir organ for SARS-CoV2?","volume":"92","author":"Gomez-Pinedo","year":"2020","journal-title":"J Med Virol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.660087\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T02:44:07Z","timestamp":1618195447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.660087\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":220,"alternative-id":["10.3389\/fneur.2021.660087"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.660087","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"article-number":"660087"}}